München
26.08.26 | 08:02
0,069 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,050 | 0,071 | 26.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.08. | Stocks in Play: Ventripoint Diagnostics Ltd | - | Baystreet.ca | ||
| 20.08. | UniDoc Health Corp.: UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform | 456 | ACCESS Newswire | Proposed collaboration would combine UniDoc's connected-care infrastructure with Ventripoint's AI-enabled cardiac imaging platform VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| 13.08. | Ventripoint broadens access to AI cardiac imaging | 3 | The Market Online Canada | ||
| 13.08. | Ventripoint Diagnostics Ltd (2): Ventripoint talks up VMS+ 4.0 access by subscription | 1 | Stockwatch | ||
| 12.08. | Ventripoint Diagnostics Ltd: Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging | 1 | GlobeNewswire (USA) | ||
| 07.08. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement | 1 | TheNewswire | ||
| 06.08. | Ventripoint Diagnostics Ltd (2): Ventripoint, UniDoc assess remote cardiac platform | 26 | Stockwatch | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 05.08. | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 05.08. | Ventripoint Diagnostics Ltd.: UniDoc Health and Ventripoint Diagnostics Sign MOU to Evaluate Scalable Remote Cardiac Assessment and Screening Platform | 40 | TheNewswire | ||
| 30.07. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Toleikis to board, grants option | 2 | Stockwatch | ||
| 29.07. | Ventripoint Diagnostics Ltd.: Ventripoint Strengthens Board with Appointment of MedTech Executive and Commercialization Leader Dr. Philip Toleikis | 2 | TheNewswire | ||
| 23.07. | Ventripoint Diagnostics Ltd (2): Ventripoint to issue shares for debenture interest | 2 | Stockwatch | ||
| 22.07. | Ventripoint Diagnostics Ltd (2): Ventripoint hires More Capital for advisory services | 2 | Stockwatch | ||
| 22.07. | Ventripoint Diagnostics Ltd.: Ventripoint Issue Shares for Payment of Debenture Interest | 1 | TheNewswire | ||
| 22.07. | Ventripoint Diagnostics Ltd.: Ventripoint Engages More Capital Ltd. | 2 | TheNewswire | ||
| 20.07. | Stocks in Play: Ventripoint Diagnostics Ltd | - | Baystreet.ca | ||
| 20.07. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics' VMS+ Technology Selected for World-First AI Cardiac Monitoring Study in Breast Cancer Patients | 1 | TheNewswire | ||
| 26.06. | Ventripoint Diagnostics Ltd (2): Ventripoint enters collaboration with Ollie Hinkle | 1 | Stockwatch | ||
| 26.06. | Stocks in Play: Ventripoint Diagnostics Ltd | - | Baystreet.ca | ||
| 26.06. | Ventripoint Diagnostics Ltd.: Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease | 1 | TheNewswire |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,300 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| TANDEM DIABETES | 18,200 | -1,09 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| MOLINA HEALTHCARE | 175,00 | +0,69 % | Tech-Bullen aufgepasst: Michael Burry wettet jetzt noch härter gegen Chip-Aktien | © Foto: DALL*EDie Micron-Aktie hat sich seit Jahresbeginn massiv verteuert. Genau jetzt legt Starinvestor Michael Burry bei Chip-Shorts nach - und bleibt auch bei Tesla und Palantir auf der Gegenseite.Michael... ► Artikel lesen | |
| VERU | 2,800 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,570 | -2,19 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SOMNIGROUP INTERNATIONAL | 54,90 | +1,74 % | Leggett & Platt Incorporated: Leggett & Platt Announces Shareholder Approval of Merger with Somnigroup | CARTHAGE, Mo., Aug. 20, 2026 /PRNewswire/ -- Leggett & Platt today announced that its shareholders voted to approve the merger of the Company with Somnigroup International... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,580 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement | SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies... ► Artikel lesen | |
| NEURONETICS | 2,490 | -2,73 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| FRESENIUS | 46,345 | +1,09 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,260 | -1,11 % | Siemens-Healthineers-Chef: 'Mir gefällt dieses Rumgenörgel nicht' | BERLIN (dpa-AFX) - Der Vorstandvorsitzende des Dax -Konzerns Siemens Healthineers, Bernhard Montag, hat die Anspruchshaltung vieler Wirtschaftslenker in Deutschland gegenüber der Politik kritisiert.... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,36 | +0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,360 | 0,00 % | Fresenius macht bei FMC Kasse - was jetzt zählt | ||
| ALIGNMENT HEALTHCARE | 13,920 | +0,14 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| HEARTFLOW | 48,920 | -0,04 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen VENTRIPOINT DIAGNOSTICS LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,069 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.